Edelstein Michael, Shibli Haneen, Bornstein Jacob
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Vaccine. 2025 Jan 12;44:126548. doi: 10.1016/j.vaccine.2024.126548. Epub 2024 Nov 28.
In Israel, The Human Papilloma Virus (HPV) vaccine is recommended to both genders up to age 26. Many 18-26 olds missed their opportunity for vaccination during school. Our study described HPV knowledge, attitudes and vaccination intentions among unvaccinated 18-26 Israeli adults across various demographics, aiming to inform future catch-up vaccination strategies. We recruited participants through an anonymous survey and collected information about demographics and HPV knowledge, attitudes and intentions using questions from validated questionnaires adapted to the Israeli context, distributed between December 2023-February 2024. We calculated weighted mean knowledge and attitude scores according to age, gender, ethnicity and sexual orientation. We determined factors associated with vaccination knowledge, attitudes and intentions using multivariate linear regressions. Of 4324 respondents, 36 % were vaccinated. Of 1994 unvaccinated individuals included in the final analysis, <50 % reported being familiar with HPV. The overall mean weighted HPV knowledge score was 9.5/14 (95 % CI 9.3-9.7). Older participants, Jewish non-Ultra-Orthodox, and those with higher education levels reported higher knowledge scores. Attitudes towards HPV vaccination were generally neutral but tended towards the positive, with an overall mean weighted score of 2.9/5 (95 %CI 2.88-2.95). Variation in attitudes across different demographic groups was minimal. Intention to vaccinate within 12 months was low, with <15 % of respondents overall expressing an intention to do so. Factors significantly associated with higher vaccination intention included being Arab, older, female, having multiple sexual partners, and being a student. There was no association between sexual orientation and vaccination intention. Arab participants showed the highest intention to vaccinate despite having the lowest knowledge levels. Young adults in Israel demonstrate low HPV awareness and vaccination intention, with minor variations in attitudes across different demographics. Providing more information may be insufficient to increase vaccine uptake in all groups. Future catch-up campaigns should be tailored to barriers specific to different groups.
在以色列,人乳头瘤病毒(HPV)疫苗被推荐给26岁及以下的男女。许多18至26岁的人在上学期间错过了接种疫苗的机会。我们的研究描述了未接种疫苗的18至26岁以色列成年人在不同人口统计学特征中的HPV知识、态度和接种意愿,旨在为未来的补种疫苗策略提供信息。我们通过一项匿名调查招募参与者,并使用根据以色列情况改编的经过验证的问卷中的问题,收集有关人口统计学以及HPV知识、态度和意愿的信息,调查于2023年12月至2024年2月期间进行。我们根据年龄、性别、种族和性取向计算加权平均知识和态度得分。我们使用多元线性回归确定与疫苗接种知识、态度和意愿相关的因素。在4324名受访者中,36%已接种疫苗。在纳入最终分析的1994名未接种疫苗的个体中,不到50%表示熟悉HPV。HPV知识总体加权平均得分为9.5/14(95%置信区间9.3 - 9.7)。年龄较大的参与者、非极端正统派犹太人以及教育水平较高的人知识得分较高。对HPV疫苗接种的态度总体上较为中立,但倾向于积极,总体加权平均得分为2.9/5(95%置信区间2.88 - 2.95)。不同人口群体之间态度的差异很小。在12个月内接种疫苗意愿较低,总体上不到15%的受访者表示有此意愿。与较高接种意愿显著相关的因素包括为阿拉伯人、年龄较大、女性、有多个性伴侣以及是学生。性取向与接种意愿之间没有关联。阿拉伯参与者尽管知识水平最低,但接种意愿最高。以色列的年轻人对HPV的认识和接种意愿较低,不同人口群体之间的态度差异较小。提供更多信息可能不足以提高所有群体的疫苗接种率。未来的补种活动应针对不同群体特有的障碍进行调整。